IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame mysterious autoimmune disease flares
Disease control OngoingThis study is testing whether a new drug called obexelimab can prevent painful and damaging flare-ups in people with IgG4-related disease, a rare autoimmune condition. About 194 adults who are currently experiencing a flare-up will receive either the study drug or a placebo injec…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Zenas BioPharma (USA), LLC • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug aims to tame rare, Multi-Organ autoimmune disease
Disease control OngoingThis study is testing whether a drug called inebilizumab can prevent disease flares in people with IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues in multiple organs. About 135 adults with active IgG4-RD who are at high risk of f…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC